Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis

Trial Identifier: D9612C09998
Sponsor: AstraZeneca
Collaborator:
IQVIA RDS Inc.
Calyx
Labcorp Central Laboratory Services
Medidata Solutions
Thermo Fisher Scientific
CISCRP (Center for Information and Study on Clinical Research Participation)
Quipment Inc.
Little Journey Ltd.
NCTID:: NCT05267613
Start Date: July 2022
Primary Completion Date: August 2026
Study Completion Date: November 2026
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AR Cordoba, AR, 5000
AR Córdoba, AR, X5016KEH
AR Parana, AR, 3100
AR Rosario, AR, S2000DEJ
AU Clayton, AU, 3168
AU North Adelaide, AU, 5006
BE Namur, BE, 5101
ES Badalona, ES, 08916
ES Santiago de Compostela, ES, 15706
ES Sevilla, ES, 41009
ES Sevilla, ES, 41013
GR Athens, GR, 11527
GR Thessaloniki, GR, 54642
GR Thessaloniki, GR, 56249
IT Messina, IT, 98125
IT Napoli, IT, 80138
IT Napoli, IT, 80131
IT Roma, IT, 00137
IT ROMA, IT, 00161
LT Kaunas, LT, LT50009
LT Vilnius, LT, LT-08406
PT Braga, PT, 4710
PT Coimbra, PT, 3000-602
PT Lisboa, PT, 1500-650
PT Lisboa, PT, 1169-045
PT Lisboa, PT, 1998-018
PT Porto, PT, 4200-319
PT Porto, PT, 4099-001
PT Viana do Castelo, PT, 4901-858
RU Novosibirsk, RU, 630007
RU Pyatigorsk, RU, 357502
RU Saint Petersburg, RU, 196240
RU Saint-Petersburg, RU, 196158
RU Tomsk, RU, 634009
US, CA Sacramento, CA, US, 95817
US, FL Miami, FL, US, 33155
US, FL Orlando, FL, US, 32806
US, IN Carmel, IN, US, 46290
US, OH Akron, OH, US, 44308
US, OH Cleveland, OH, US, 44195
US, WI Milwaukee, WI, US, 53226
VN Ha Noi, VN, 100000
VN Hanoi, VN, 100000
VN Hanoi, VN, 10000
VN Hochiminh, VN